Argon AI has introduced it secured $5.5 million in seed funding.
Crosslink Capital and Wireframe Ventures co-led the spherical, with participation from Y Combinator, Pioneer Fund and different buyers.
WHAT IT DOES
Argon AI provides a platform geared toward serving to life sciences firms automate data-intensive workflows. Its AI assistants assist with repetitive, handbook and rote duties throughout medical and business work.
The AI-enabled platform additionally unifies varied codecs of trade knowledge, together with structured tables, PDFs, slide decks and pictures, throughout completely different knowledge sources comparable to medical literature, firm info and convention proceedings.
The corporate will use the funds for product enhancements, staff improvement and buyer growth.
“Each business or medical technique determination is constructed on high of fragmented, outdated or hard-to-access info,” Samy Danesh, CEO and cofounder of Argon AI, stated in an announcement.
“We’re constructing Argon to make data as accessible and actionable as your inbox and to free life sciences groups to deal with bringing new remedies to sufferers.”
MARKET SNAPSHOT
Different firms within the knowledge workflow area embrace Plenful, a workflow-automation platform for pharmacy and healthcare operations, which in 2024 secured $17 million in Sequence A funding lower than a 12 months after launching with $9 million in funding.
Plenful provides pharmacy technicians a no-code, AI-enabled automation device for handbook and administrative workflows, together with assist with doc knowledge entry for pharmacy income cycle, referral orders, auditing and financial savings identification.
The corporate used the funds to scale its advertising, gross sales and product improvement efforts.
That very same 12 months, SamaCare, a workflow platform for suppliers providing specialty remedy, introduced it secured $17 million in an oversubscribed Sequence B funding spherical.
The corporate provides a cloud-based workflow automation platform to help suppliers in acquiring prior authorization for specialty drug drugs, verifying enrollment and checking advantages.
It additionally works with pharmaceutical firms to offer knowledge analytics to assist enhance entry to their therapies.
The corporate used the funds to increase its Script-to-Remedy Working System, which can leverage AI for administrative duties, create a post-prescription workflow, accumulate knowledge insights and improve collaboration between suppliers’ places of work.
